MDAI
Spectral AI, Inc.NASDAQHealthcare$1.45+0.69%ClosedMarket Cap: $46.1M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
-8.78
P/S
2.72
EV/EBITDA
-5.46
DCF Value
$-7.52
FCF Yield
-18.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
44.4%
Operating Margin
-45.5%
Net Margin
-41.1%
ROE
129.2%
ROA
-37.3%
ROIC
-202.5%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $3.8M | $642.0K | $0.02 |
| FY 2025 | $19.6M | $-7.6M | $-0.29 |
| Q3 2025 | $3.8M | $-3.6M | $-0.13 |
| Q2 2025 | $5.1M | $-8.0M | $-0.31 |
Analyst Ratings
View AllBTIGBuy
2026-03-25BTIGBuy
2026-02-10BTIGBuy
2025-11-12Trading Activity
Insider Trades
View AllDiMaio John Michaeldirector
SellTue Jun 10
DiMaio John Michaeldirector
SellTue Jun 10
Mellish Martin C.B.director
SellFri Jun 06
Cotton Richard Johndirector
SellThu May 01
Mellish Martin C.B.director
SellWed Apr 30
Company Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
0.91
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.